FDA OKs New Therapy for Some Hemophilia Patients - NBC Connecticut
National & International News
The day’s top national and international news

FDA OKs New Therapy for Some Hemophilia Patients

Genentech, the drug's developer, says the list price will be about $482,000 for the first year and slightly less after that

    processing...

    NEWSLETTERS

    The new way doctors are treating cleft lip and palate
    AP/Genentech, Inc.
    This photo provided by Genentech, Inc. shows a package of the drug Hemlibra. On Thursday, Nov. 16, 2017, the Food and Drug Administration approved Hemlibra, the first new treatment in nearly two decades to prevent internal bleeding in certain patients with hemophilia, an inherited blood-clotting disorder.

    U.S. regulators have approved the first new treatment in nearly two decades to prevent internal bleeding in certain patients with hemophilia, an inherited blood-clotting disorder.

    The Food and Drug Administration on Thursday approved Hemlibra (hem-LEE'-bruh), a weekly injection for hemophilia A patients who have developed resistance to standard medicines.

    Genentech, the drug's developer, says the list price will be about $482,000 for the first year and slightly less after that.

    Genentech, a subsidiary of Swiss drugmaker Roche, says that's half the cost of the only other option for patients with this resistance. That treatment requires an IV drip several times a week.

    3 Children Die in Freezer in Apparent Horrifying Accident

    [NATL-NY] Kids' Bodies Found in Freezer in Apparent Horrifying Accident

    Investigators believe three children, ages 1, 4 and 6, died after becoming trapped in a freezer outside of their Florida home -- a horrifying apparent accident that has rattled the community. WNBW's Josslyn Howard reports.

    (Published Wednesday, Jan. 16, 2019)

    Hemophilia mostly affects males.